First Time Loading...
Y

Youngy Health Co Ltd
SZSE:300247

Watchlist Manager
Youngy Health Co Ltd
SZSE:300247
Watchlist
Price: 2.95 CNY 1.03% Market Closed
Updated: May 7, 2024
Section:
 

Wall Street
Price Targets

Price Targets Summary
Youngy Health Co Ltd

There are no price targets for Youngy Health Co Ltd.
Lowest Forecast
Wall Street Target
Not Available
Average Forecast
Wall Street Target
Not Available
Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Youngy Health Co Ltd Competitors:
Price Targets
S
024950
Samchuly Bicycle Co Ltd
473% Upside
1736
Johnson Health Tech Co Ltd
62% Upside
ESCA
Escalade Inc
54% Upside
T
4536
Topkey Corp
5% Upside
S
024950
Samchuly Bicycle Co Ltd
473% Upside
1736
Johnson Health Tech Co Ltd
62% Upside
ESCA
Escalade Inc
54% Upside
T
4536
Topkey Corp
5% Upside
MODG
Topgolf Callaway Brands Corp
23% Upside
603579
Shanghai Rongtai Health Technology Corp Ltd
8% Upside
6238
FuRyu Corp
60% Upside
7309
Shimano Inc
9% Downside

Revenue
Forecast

Revenue Estimate
Youngy Health Co Ltd

For the last 8 years the compound annual growth rate for Youngy Health Co Ltd's revenue is 6%. The projected CAGR for the next 6 years is 6%.

6%
Past Growth
6%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Youngy Health Co Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Youngy Health Co Ltd

For the last 8 years the compound annual growth rate for Youngy Health Co Ltd's net income is 26%. The projected CAGR for the next 6 years is -7%.

26%
Past Growth
-7%
Estimated Growth
Estimates Accuracy
12%
Average Beat
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Youngy Health Co Ltd's stock price target?
Not Available

Youngy Health Co Ltd doesn't have any price targets made by Wall Street professionals.

What is Youngy Health Co Ltd's Revenue forecast?
Projected CAGR
6%

For the last 8 years the compound annual growth rate for Youngy Health Co Ltd's revenue is 6%. The projected CAGR for the next 6 years is 6%.

What is Youngy Health Co Ltd's Net Income forecast?
Projected CAGR
-7%

For the last 8 years the compound annual growth rate for Youngy Health Co Ltd's net income is 26%. The projected CAGR for the next 6 years is -7%.

ALPHA SPREAD
Join more than 135,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.